Summary
- Current Price
- As of today, EWTX price is $29.70, down -2.43% on
- Current Price All-Time High
- EWTX price is currently -26.65% below its historical high of $40.49 set on
- Market Cap
- EWTX current market cap is $3B, up +26.20% over the past 365 days
- PE Ratio
- EWTX PE ratio is unknown
- Revenue
- EWTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for EWTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Edgewise Therapeutics, Inc. |
| Ticker | NASDAQ: EWTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | edgewisetx.com |
| Employees | 117 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $29.70 | |
| Price, 1D Change | -2.43% | |
| $3B | ||
| - | ||
| - | ||
| 1.10 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| $0.00 | ||
| EPS, 1Y Change | +100.00% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| EPS Estimate | N/A | -$2.14 |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $29.70 | |
| Price Target | - | $43.50 |
| Price Tgt. Change | - | +46.46% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.49 | -$1.45 | +3.11% | |
| -$1.60 | $0.00 | +100.00% | |
| -$2.14 | N/A | - | |
| -$2.33 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $19.95M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $29.70 | |
| $18.94 | ||
| SMA 200 vs Price | -36.22% | |
| $27.41 | ||
| SMA 50 vs Price | -7.73% | |
| 1.10 | ||
| $1.56 | ||
| 52.93 | ||
| 33.98% | ||
| 80.03% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| -$191.41M | ||
| - | ||
| -$167.80M | ||
| - | ||
| -$189.14M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 19.85 | ||
| 19.85 | ||
| - | ||
| - | ||
| 61.91 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 6.02 | ||
| -13.84 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $522.26M | ||
| $530.11M | ||
| $552.60M | ||
| $543.39M | ||
| $30.35M | ||
| $27.37M | ||
| $3.99M | ||
| $1.01M | ||
| $6.01M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $167.80M | ||
| $189.14M | ||
| $2.27M | ||
| $40.02M | ||
| $2.27M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$143.82M | ||
| -$32.79M | ||
| $196.09M | ||
| $256.00K | ||
| -$144.07M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | → | |
| JP Morgan | → | |
| Wedbush | → | |
| RBC Capital | → | |
| Goldman Sachs | ||
| JP Morgan | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | ||
| RBC Capital | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with EWTX
FAQ
What is the ticker symbol for Edgewise Therapeutics, Inc.?
The ticker symbol for Edgewise Therapeutics, Inc. is NASDAQ:EWTX
Does Edgewise Therapeutics, Inc. pay dividends?
No, Edgewise Therapeutics, Inc. does not pay dividends
What sector is Edgewise Therapeutics, Inc. in?
Edgewise Therapeutics, Inc. is in the Healthcare sector
What industry is Edgewise Therapeutics, Inc. in?
Edgewise Therapeutics, Inc. is in the Biotechnology industry
What country is Edgewise Therapeutics, Inc. based in?
Edgewise Therapeutics, Inc. is headquartered in United States
When did Edgewise Therapeutics, Inc. go public?
Edgewise Therapeutics, Inc. initial public offering (IPO) was on March 26, 2021
Is Edgewise Therapeutics, Inc. in the S&P 500?
No, Edgewise Therapeutics, Inc. is not included in the S&P 500 index
Is Edgewise Therapeutics, Inc. in the NASDAQ 100?
No, Edgewise Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Edgewise Therapeutics, Inc. in the Dow Jones?
No, Edgewise Therapeutics, Inc. is not included in the Dow Jones index
When was Edgewise Therapeutics, Inc. last earnings report?
Edgewise Therapeutics, Inc.'s most recent earnings report was on February 26, 2026
When does Edgewise Therapeutics, Inc. report earnings?
The next expected earnings date for Edgewise Therapeutics, Inc. is May 7, 2026
Data Sources & References
- EWTX Official Website edgewisetx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1710072/000110465926020112/0001104659-26-020112-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1710072/000110465926020112/0001104659-26-020112-index.htm
- EWTX Profile on Yahoo Finance finance.yahoo.com/quote/EWTX
- EWTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ewtx